Literature DB >> 308826

Renal damage during treatment with antirheumatic drugs.

P A Dieppe, D V Doyle, H C Burry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 308826      PMCID: PMC1607408          DOI: 10.1136/bmj.2.6138.664

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  1 in total

1.  Evidence of gentamicin nephrotoxicity in patients with renal allografts.

Authors:  J M Wellwood; P M Simpson; J R Tighe; A E Thompson
Journal:  Br Med J       Date:  1975-08-02
  1 in total
  11 in total

Review 1.  The kidney in rheumatic diseases.

Authors:  H A Bird
Journal:  Ann Rheum Dis       Date:  1989-12       Impact factor: 19.103

2.  Urinary N-acetyl-beta-D glucosaminidase (NAG) level in idiopathic nephrotic syndrome.

Authors:  Om P Mishra; Priyanka Jain; Pradeep Srivastava; Rajniti Prasad
Journal:  Pediatr Nephrol       Date:  2011-11-05       Impact factor: 3.714

Review 3.  The third Lilly Prize Lecture. University of London, January, 1979. The nephrotoxicity and hepatotoxicity of antipyretic analgesics.

Authors:  L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

4.  Evaluation of urinary elimination of N-acetyl-beta-glucosaminidase in healthy volunteers treated with dibekacin or gentamicin.

Authors:  J Camí; J Segura; J E Baños; I Garcia; L Drobnic
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

Review 5.  Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics.

Authors:  L F Prescott
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

6.  Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.

Authors:  L O Erikson; E Wåhlin-Boll; I Odar-Cederlöf; L Lindholm; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 7.  Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-10       Impact factor: 9.546

8.  An assessment of tenoxicam, a nonsteroidal anti-inflammatory drug of long half-life, in patients with impaired renal function suffering from osteoarthritis or rheumatoid arthritis.

Authors:  H A Bird; A K Clarke; P D Fowler; S Little; M R Podgorski; J Steiner
Journal:  Clin Rheumatol       Date:  1989-12       Impact factor: 2.980

9.  The effects of levamisole on urinary enzyme measurements and proximal tubule cell inclusions in male rats.

Authors:  G O Evans; D A Goodwin; C E Parsons; N G Read
Journal:  Br J Exp Pathol       Date:  1988-04

Review 10.  Hazard evaluation of chemicals that cause accumulation of alpha 2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats.

Authors:  G C Hard; I S Rodgers; K P Baetcke; W L Richards; R E McGaughy; L R Valcovic
Journal:  Environ Health Perspect       Date:  1993-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.